Lenire from Neuromod delivers tinnitus improvement 'not demonstrated for any other treatment,' according to expert consensus

'Textbook of Tinnitus' is a comprehensive textbook that describes tinnitus, how it is caused, and state-of-the art interventions such as Lenire.Top-ranked tinnitus expert authors of the Textbook of Tinnitus state that Lenire's clinical trial results are remarkable and demonstrate results not seen in any other accepted tinnitus care intervention.91% of patients in Lenire's second large-scale clinic trial, TENT-A2, reported long-term relief from tinnitus that lasted at least 12-months.[2]Lenire has been proven to be more effective than sound-alone for patients with moderate or worse tinnitus in Lenire's controlled large-scale clinical trial, TENT-A3.[3]Lenire was awarded a De Novo Grant from the US FDA, making it the first and only FDA Approved bimodal neuromodulation tinnitus treatment device.(2022).
3. TENT-A3 clinical trial data in preparation for publication. https://clinicaltrials.gov/ct2/show/NCT05227365 4. https://www.nidcd.nih.gov/health/tinnitus.
4. R. Biswas et al., Tinnitus prevalence in Europe: a multi-country cross-sectional population study, The Lancet Regional Health (2021), https://doi.org/10.1016/j.lanepe.2021.100250.

Photo: https://mma.prnewswire.com/media/2398648/Lenire_Neuromod_Devices.jpg

View original content:https://www.prnewswire.co.uk/news-releases/lenire-from-neuromod-delivers-tinnitus-improvement-not-demonstrated-for-any-other-treatment-according-to-expert-consensus-302128766.html

@ prnewswire.co.uk

Hol dir den Wissensvorsprung der Profis. Seit 2005 liefert der Börsenbrief trading-notes verlässliche Trading-Empfehlungen – dreimal die Woche, direkt in dein Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr.
Jetzt anmelden.